Validation of Prognostic and Predictive Models for Therapeutic Response in Patients Treated with [177Lu]Lu-PSMA-617 Versus Cabazitaxel for Metastatic Castration-resistant Prostate Cancer (TheraP): A Post Hoc Analysis from a Randomised, Open-label, Phase 2 Trial

Andrei Gafita, Andrew Martin, Louise Emmett, Matthias Eiber, Amir Iravani, Wolfgang P. Fendler, James P Buteau, Shahneen Sandhu, Arun Azad, Ken Herrmann, Martin R. Stockler, Ian D. Davis, Michael S. Hofman